What is TRACE-T1D?
TRACE-T1D is the 'TRends in continuous glucose monitoring measures of glycaemic variability in Australian Children with Early-stage Type 1 Diabetes' study.
The study aims to learn about what happens to glucose (sugar) levels in young Australians who are found to have type 1 diabetes (T1D) related antibodies to understand how and when these change in those who go on to need insulin treatment.
In this study, participants will be asked to wear a continuous glucose monitoring device (CGM) every 3 to 12 months. The CGM system will measure glucose levels every 5 minutes, 24 hours a day for 10 days in a row. These measurements will give us detailed information on glucose levels and patterns whilst going about your usual life. The CGM data will be shared with you/r child’s referring doctor who will discuss them with you.
Who is eligible?
- Children and teenagers aged between 2 and 18 years, AND
- Have tested positive to having one or more type 1 diabetes (T1D) related antibodies, AND
- Live in Australia
Who is not eligible?
- Someone diagnosed with T1D being treated with insulin.
- A participant, or their legal guardian, who is unable to give consent to participate.
- Anyone living outside of Australia.
What is involved?
To participate in TRACE-T1D you need to be referred by the doctor looking after your child/teenager. After you have been referred you will be contacted by a member of the TRACE-T1D team who will:
- Phone you to provide more information about the study.
- Email or post you the participant information sheet and make an appointment where you can ask for more details or any questions you have about the study.
- If you wish to participate, you will be asked to confirm that you understand the information provided and, if applicable, that you have the authority to provide consent for the participant.
- Study equipment will be sent to you via registered post for you to insert on you/r child/teenager at home.
- You will be asked to return the study equipment back to the TRACE-T1D team via a pre-paid satchel.
- The study team will provide the data collected from the CGM wear period to your referring doctor who will then discuss these results with you and advise when to have your next CGM session.
Are you a clinician wanting to refer a patient? Please email diabetes.research@health.wa.gov.au or click here.